Astec Lifesciences has informed that it has enclosed the disclosure on Related Party Transactions for the Half Year ended September 30, 2019 on a consolidated basis, drawn in accordance with the applicable Accounting Standards.
The above information is a part of company’s filings submitted to BSE.